Skip to main content
SpringerLink
Log in

Congenital Disorders of Glycosylation (CDG), Neuromuscular Related Diseases

  • Chapter
  • First Online:
Glycoscience: Basic Science to Applications

  • 469 Accesses

Abstract

CDG, Mass spectrometry, Rare diseases, Next-generation sequencing

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

References Section for 17.1

  1. Jaeken J (2011) Congenital disorders of glycosylation (CDG): it’s (nearly) all in it! J Inherit Metab Dis 34:853–858

    Article  CAS  Google Scholar 

  2. Hennet T (2012) Diseases of glycosylation beyond classical congenital disorders of glycosylation. Biochim Biophys Acta 1820:1306–1317

    Article  CAS  Google Scholar 

  3. Wada Y (2016) Mass spectrometry of transferrin and apolipoprotein C-III for diagnosis and screening of congenital disorder of glycosylation. Glycoconj J 33:297–307

    Article  CAS  Google Scholar 

References Section for 17.2

  1. Suzuki T (2015) The cytoplasmic peptide: N-glycanase (PNGase) – basic science encounters a human genetic disorder. J Biochem 157:23–34

    Article  CAS  Google Scholar 

  2. Lam C et al (2017) Prospective phenotyping of NGLY1-CDDG, the first congenital disorder of deglycosylation. Genet Med 19:160–168

    Article  Google Scholar 

  3. Huang C et al (2015) Endo-β-N-acetylglucosaminidase forms N-GlcNAc protein aggregates during ER-associated degradation in Ngly1-defective cells. Proc Natl Acad Sci U S A 112:1398–1403

    Article  CAS  Google Scholar 

  4. Tomlin FM et al (2017) Inhibition of NGLY1 inactivates the transcription factor Nrf1 and potentiates proteasome inhibitor cytotoxicity. ACS Cent Sci 3:1143–1155

    Article  CAS  Google Scholar 

  5. Fujihira H et al (2017) Lethality of Ngly1-knockout mice is partially rescued by the additional deletion of the Engase gene. PLoS Genet 13:e1006696

    Article  Google Scholar 

References Section for 17.3

  1. Endo T (2015) Glycobiology of α-dystroglycan and muscular dystrophy. J Biochem 157:1–12

    Article  CAS  Google Scholar 

  2. Chiba A et al (1997) Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of α-dystroglycan with laminin. J Biol Chem 272:2156–2162

    Article  CAS  Google Scholar 

  3. Yoshida A et al (2001) Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 1:717–724

    Article  CAS  Google Scholar 

  4. Yoshida-Moriguchi T et al (2010) O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science 327, 88–92

    Article  CAS  Google Scholar 

  5. Kanagawa M et al (2016) Identification of a post-translational modification with ribitol-phosphate and its defect in muscular dystrophy. Cell Rep 14:2209–2223

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Osaka Women’s and Children’s Hospital, Izumi, Japan

    Yoshinao Wada

  2. RIKEN, Wako, Japan

    Tadashi Suzuki

  3. Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan

    Tamao Endo

Authors
  1. Yoshinao Wada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tadashi Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tamao Endo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yoshinao Wada , Tadashi Suzuki , Tamao Endo , Yoshinao Wada , Tadashi Suzuki or Tamao Endo .

Editor information

Editors and Affiliations

  1. Osaka International Cancer Institute, Osaka, Japan

    Naoyuki Taniguchi

  2. Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan

    Tamao Endo

  3. National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan

    Jun Hirabayashi

  4. Soka University, Hachioji, Japan

    Shoko Nishihara

  5. Nagoya University, Nagoya, Japan

    Kenji Kadomatsu

  6. Kyoto University, Kyoto, Japan

    Kazunari Akiyoshi

  7. Soka University, Hachioji, Japan

    Kiyoko F. Aoki-Kinoshita

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wada, Y., Suzuki, T., Endo, T. (2019). Congenital Disorders of Glycosylation (CDG), Neuromuscular Related Diseases. In: Taniguchi, N., et al. Glycoscience: Basic Science to Applications. Springer, Singapore. https://doi.org/10.1007/978-981-13-5856-2_17

Download citation

Publish with us

Policies and ethics

Search

Navigation